This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New PCMA Ad Campaign: 'It's The Oklahoma Drugstore Lobby Vs. Employers'

New Regulations Could Increase Prescription Drug Costs $1.7 Billion

WASHINGTON, March 26, 2013 /PRNewswire-USNewswire/ -- As the Oklahoma drugstore lobby launches new attacks seeking to undermine tools used by pharmacy benefit managers (PBMs) to lower prescription drug costs, the Pharmaceutical Care Management Association (PCMA) released a new ad campaign defending the rights of employers to reduce wasteful pharmacy spending. As the ad says, employers think, "It's wrong" for the Oklahoma drugstore lobby "to force businesses to pay more for prescription drugs." 

"The agenda promoted by the Oklahoma drugstore lobby would enrich pharmacies by making every other business pay more for prescription drugs," said PCMA President and CEO Mark Merritt.

This special interest legislation (H.B. 2100) could increase prescription drug costs $1.7 billion for the state's employers, seniors, state employee plans, unions, and consumers.

Click here to see the new ad.

"It's the Oklahoma Drugstore Lobby vs. Employers in the Fight to Reduce Prescription Drug Costs" Vote NO on H.B. 2100

The Oklahoma drugstore lobby agenda includes:
  • New employer mandates that raise costs and reduce choices.
  • Giving drugstores new powers to charge consumers more for prescription drugs.
  • Forcing employers to pay more for prescription drugs.

The Federal Trade Commission examined similar Board of Pharmacy legislation and found it would make "collusion easier and increase prescription drug prices if the Pharmacy Board obtains and discloses PBMs' competitively sensitive information to pharmaceutical manufacturers, pharmacists, and pharmacies."

A recent legal analysis from Bloomberg/BNA that examined State of Boards of Pharmacy also noted:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs